RNA Modifications: Bridging Biological Function and Therapeutic Potential (C2)
March 9-12, 2026
| Keystone Resort, Keystone, CO, United States
Michaela Frye, Schraga Schwartz, Yunsun Nam and Eckhard Jankowsky
Scholarship Deadline: Nov. 6, 2025 | Abstract Deadline: Feb. 17, 2026 | Early Registration Deadline: Jan. 8, 2026
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
| 12:15–1:00 PM |
Poster Setup |
|
| 12:15–5:00 PM |
On Own for Lunch |
|
| 8:00–9:00 AM |
Welcome and Keynote Address |
|
| |
Tsutomu Suzuki, University of Tokyo
Expanding Chemical Space of RNA Modifications |
|
| 9:00–11:15 AM |
Molecular Mechanisms of RNA Modifications |
|
| |
Caroline Köhrer, Alltrna
tRNA Therapeutics |
|
| |
Yunsun Nam, University of Texas Southwestern Medical Center
Structure and Function of RNA Modifying Protein |
|
| |
Sara H. Rouhanifard, Northeastern University
RNA Modifications on the Single Molecular Level and Spatial Transcriptomics |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 11:15–12:15 PM |
Meet the Editors |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 2:30–4:30 PM |
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Language Models Predicting RNA Modifications and Functions |
|
| |
Schraga Schwartz, Weizmann Institute of Science
Computational and Functional Analyses of Modifications |
|
| |
Prashant Mali, University of California, San Diego
Transcriptome Engineering Toolsets |
|
| |
Eduardo Eyras, EMBL Australia, Australian National University
Machine Learning to Study Transcriptomes and Epitranscriptomes in RNA Biology and Cancer. |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 7:30–10:00 PM |
Poster Session 1 |
|
Wednesday, March 11, 2026
| 8:00–11:00 AM |
RNA Therapeutics |
|
| |
Peter C. Dedon, Massachusetts Institute of Technology
High Throughput Platforms for Epitranscriptomic Drug Discovery |
|
| |
Olivier Duss, European Molecular Biology Laboratory
Dynamic RNA Biology at the Single-Molecule Level: Watching how Interconnected Processes Work in Real-Time |
|
| |
Eckhard Jankowsky, Moderna
Biogenesis and Function of RNA Modifications |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–1:00 PM |
Poster Setup |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 1:45–3:15 PM |
Career Roundtable |
|
| 3:30–4:30 PM |
Panel Discussion: Science Meets Industry |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
RNA Modifications in Diseases I |
|
| |
Samie Jaffrey, Weill Medical College of Cornell University
Cap Modifications in Healthy Cells and Disease |
|
| |
Jordan L Meier, National Cancer Institute
Cytidine Acetylation across the Tree of Life |
|
| |
Michaela Frye, Deutsches Krebsforschungszentrum
tRNA Modifications in Cancer |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 7:30–10:00 PM |
Poster Session 2 |
|
| 8:00–11:00 AM |
RNA Engineering and Editing Approaches |
|
| |
Namita Bisaria, AIRNA
Therapeutics based on ADAR -Base Editing |
|
| |
Nicole Martinez, Stanford University
RNA Modifications and Pre-mRNA Processing |
|
| |
Kate Meyer, Duke University
Genetically Encoded Tools for Studying mRNA Methylation |
|
| |
Jin Billy Li, Stanford University
RNA Editing and Sensing as a Common Mechanism Underlying the Genetic Risk of Inflammation |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 12:00–5:00 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–6:45 PM |
RNA Modifications Diseases II |
|
| |
Zoya Ignatova, University of Hamburg
tRNA Engineering to Suppress Nonsense Mutations in Disease |
|
| |
Victoria H. Cowling, Cancer Research UK Scotland Institute
RNA Cap Modifications in T Cell Function |
|
| |
Chuan He, University of Chicago
RNA Modifications in Physiology and Immune-Related Disease |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:45–7:30 PM |
Closing Keynote Address |
|
| |
Muthiah Manoharan, Alnylam Pharmaceuticals, Inc.
siRNA Therapeutics |
|
| 7:30–7:45 PM |
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
|
| 7:45–8:45 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Entertainment |
|
